电子邮件 | rmi***@***.com | 获取Email |
---|
电子邮件 | rmi***@***.com | 获取Email |
---|
Invero Pharma believes xenon holds great promise due to its multiple mechanisms of action, extensive pre-clinical results² and positive Phase II clinical trial results which demonstrated a reduction in brain tissue damage and directionally better survival outcomes. Invero Pharma intends to become a leader in the development and commercialization of drug/device neuroprotective products that help prevent brain damage and improve mortality rates in patient populations experiencing acute injury to the brain. ¹ Laitio et. al. ,JAMA. 2016;315(11):1120-1128. doi:10.1001/jama.2016.1933 ² Maze, Can J Anesth/J Can Anesth. DOI 10.1007/s12630-015-0507-8
公司 | Invero Pharma |
---|---|
职位 | VP, Chief Business Officer |
地点 | United States |
http://www.linkedin.com/in/robertmilos | |
部门 | |
头衔 | VP, Chief Business Officer |
Invero Pharma VP, Chief Business Officer
2021-06-01 -
Chief Business Development Officer
2019-12-01 -
Associate Director
2016-04-01 - 2017-07-01
Chief Business Officer
2016-02-01 - 2019-12-01
Strategy & Business Development
2010-10-01 - 2014-09-01
Robert Milos 在 Invero Pharma 担任 VP, Chief Business Officer
Robert Milos 在 Invero Pharma 的职位是 VP, Chief Business Officer
Robert Milos 的电子邮件地址是 rmi***@***.com
Robert Milos 的电话号码是 -
Robert Milos 的公司电话号码是 -
Robert Milos 在 pharmaceuticals 工作。
Robert Milos 的一些同事包括Robert Milos、Ken Liss、Doug StefanelliMatt Napoletano、。
Robert Milos联系方式: 电子邮件地址:rmi***@***.com 电话号码:-
Robert Milos 的个人领英是:http://www.linkedin.com/in/robertmilos
Robert Milos 的办公地点:-, Montville, New Jersey, USA, 07004
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd